ONE-WAYOngoing theme · still written in the latest filings
U.S. Approval and Commercialization of Anti-Adhesion and Hemostatic Materials
A project aimed at commercializing anti-adhesion and hemostatic materials in the United States by advancing discussions with the FDA and selecting candidate products, while collecting clinical data and preparing a U.S. regulatory submission.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.